Alphatec Holdings, Inc. (ATEC) Stock

Alphatec Holdings, Inc., a leading medical technology firm, specializes in designing, developing, and advancing surgical technologies tailored for treating spinal disorders. The company's comprehensive product portfolio includes a wide range of implants and instruments manufactured and distributed through third-party suppliers. Among its innovative offerings are the SafeOp Neural InformatiX System, part of the Alpha InformatiX product platform, designed to enhance surgical outcomes through advanced neural monitoring.

Alphatec also offers specialized systems like the Sigma PTP Access and Patient Positioning System, split-blade retractors, and the Sigma-ALIF Access System, which streamline procedural access for specific surgical techniques. The company integrates cutting-edge imaging solutions such as the EOS imaging system, providing full-body imaging capabilities that aid in precise treatment planning and execution.

In addition to its hardware solutions, Alphatec provides a robust lineup of biologics, including the 3D ProFuse Osteoconductive Bioscaffold and AlphaGRAFT Cellular Bone Matrix, enriched with growth factors to promote effective bone healing. The company's product suite also features innovative solutions like the BioCORE Moldable Bioactive Graft and Amnioshield Amniotic Tissue Barrier, enhancing surgical outcomes with advanced biocompatible materials.

Founded in 1990 and headquartered in Carlsbad, California, Alphatec Holdings continues to expand its global footprint through a network of independent sales agents and direct sales representatives. The company remains committed to pioneering advancements in spinal surgery technologies, driven by a dedication to improving patient outcomes and quality of life.